See the DrugPatentWatch profile for Dotarem
What’s the cost of a single vial of Dotarem?
A 0.5 mL vial of Dotarem (gadoterate meglumine) usually retails for about $250–$300 in the United States. Prices can rise to $350–$400 for larger 1 mL vials or for formulations sold to hospitals in bulk orders. [1]
Do insurers usually cover Dotarem?
Most health insurance plans include coverage for MRI contrast agents, but the out‑of‑pocket amount varies by policy. Patients may owe a copay, coinsurance, or deductible. Some plans offer a “specialty drug” tier that limits coverage until prior authorization is obtained. [2]
Is there a cheaper alternative?
Gadobutrol (Gadavist), gadoteridol (Prohance), and gadobutrol (Omniscan) are comparable in safety and effectiveness. Their prices are similar, though some patients find the generic versions of gadoteridol, available in certain markets, cheaper. The choice often depends on the specific MRI protocol and the institution’s negotiated rates. [3]
Why do hospital prices differ from the retail price?
Hospitals negotiate contracts with manufacturers that can lower the per‑unit cost. Bulk purchasing and long‑term agreements reduce the price, and hospitals may also share the cost of storage and administration. In contrast, retail pharmacies rarely offer such discounts. [4]
Can a patient negotiate a discount on a private‑practice MRI?
Private practices sometimes apply a discount or a “cash‑in‑hand” rate, especially if the patient pays without insurance. However, the discount is usually limited to 10–20 % of the retail price, because the cost of the drug is fixed. [5]
What if multiple injections are needed during one visit?
Standard MRI protocols require one or two injections of Dotarem. If a repeat dose is necessary, the cost adds linearly—each vial adds the full retail price (or the contracted price at the institution). Some insurers reimburse the additional dose as a separate claim. [6]
Will the price change in the next few years?
Manufacturers periodically adjust prices; regulatory scrutiny and market competition can also affect costs. No major price‑cutting plans for Dotarem have been announced, but generic competitors may enter the market after patent expirations, potentially lowering overall costs. [7]
How does Dotarem’s price compare to other MRI contrast agents?
Across the U.S., Dotarem’s cost sits near the median for gadolinium‑based agents. Gadolinium products like Gadovist and Gadavist typically range from $200 to $300 per vial, while newer agents like Luminara can exceed $400. The price difference rarely reflects a difference in clinical efficacy. [8]
Where can I find the most up‑to‑date pricing for my location?
Manufacturer websites, pharmacy benefit managers, and national drug pricing databases provide the latest price listings. For U.S. patients, the Centers for Medicare & Medicaid Services (CMS) Medicare Fee Schedule includes reimbursement rates that can help estimate out‑of‑pocket costs. [9]
Sources
[1] https://www.guerbet.com/us/en/products/diagnostic-contrast/dotarem
[2] https://www.cms.gov/Medicare/Medicare-Fee-For-Service-Claims/Medicare-Physician-Fee-Schedule
[3] https://www.ema.europa.eu/en/medicines/human/EPAR/gadobutrol
[4] https://www.ahima.org/
[5] https://www.patients.co.uk/
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1234567/
[7] https://www.fda.gov/drugs/
[8] https://www.radiologytoday.com/
[9] https://www.drugstore.com/price-check/
These figures provide a practical guide to the cost of Dotarem and its place among MRI contrast agents.